Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01WKR
|
||||
Former ID |
DIB019806
|
||||
Drug Name |
eGlu
|
||||
Synonyms |
EGLU; (s)-alpha-ethylglutamate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [538877] | ||
Structure |
Download2D MOL |
||||
Formula |
C7H13NO4
|
||||
InChI |
InChI=1S/C7H13NO4/c1-2-7(8,6(11)12)4-3-5(9)10/h2-4,8H2,1H3,(H,9,10)(H,11,12)/t7-/m0/s1
|
||||
InChIKey |
QFYBYZLHPIALCZ-ZETCQYMHSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Metabotropic glutamate receptor3 | Target Info | Antagonist | [525820] | |
Metabotropic glutamate receptor 2 | Target Info | Antagonist | [525820] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Ionotropic glutamate receptor pathway | |||||
Metabotropic glutamate receptor group II pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Metabotropic glutamate receptor group II pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.